A substantive restructuring and expansion. v2 introduces a new section modifying housing loan fees, unrelated to the bill's original focus. For the TBI grant programs, v2 significantly tightens eligibility criteria, expands reporting and oversight requirements, and adds new provisions for coordination with VA facilities and human subjects protections.
BEACON Act of 2026
- Sponsor
- Rep. Bergman, Jack [R-MI-1]
- Committees
- Veterans' Affairs Committee (primary)
- Last action
- Oct 1, 2026
Bottom line
The BEACON Act of 2026 aims to expand and improve neurorehabilitation treatments for veterans with chronic mTBI through federally funded research and grant programs, while also making a minor adjustment to VA housing loan fees.
What it actually does
This bill establishes two distinct grant programs within the Department of Veterans Affairs (VA) to fund research and treatment for chronic mild traumatic brain injury (mTBI) in veterans. The first program, the "TBI Innovation Grant Program," directly awards grants to eligible entities for developing and evaluating neurorehabilitation treatments. The second program awards grants for independent third-party research studies and treatment, with its administration potentially overseen by an independent organization. Additionally, the bill includes a provision to extend certain VA housing loan fees.
Proponents argue
Supporters argue that the bill addresses a critical and unmet need for effective, non-pharmacological treatments for chronic mTBI, a condition highly prevalent among the veteran population. They contend that by funding innovative research and rigorous clinical trials, the bill will lead to better health outcomes for veterans suffering from persistent symptoms, including improved mental health and reduced suicidality, and will foster essential coordination between the VA and external experts.
Opponents contend
Critics might argue that while the bill's intent to support veterans is laudable, establishing new, separate grant programs could introduce administrative overhead and potentially duplicate existing VA research efforts. Concerns could also be raised regarding the oversight of independent organizations and ensuring that grant funds are efficiently and effectively utilized to produce tangible benefits for veterans, rather than primarily funding research without clear pathways to clinical application.
The bill is moderately complex, requiring careful reading to understand the distinct structures of the two grant programs and their administrative requirements. An informed reader would need sufficient time to grasp the nuances of each program's scope, oversight, and coordination mandates.
Section 1
Short Title
This section establishes the official short title of the Act as the "Veterans TBI Breakthrough Exploration of Adaptive Care Opportunities Nationwide Act of 2026" or, more concisely, the "BEACON Act of 2026." This provides a common, abbreviated name for referring to the legislation in public discourse and legislative tracking.
Supporters argue
Supporters argue that a clear and memorable short title aids in public understanding and legislative tracking, making the bill's purpose more accessible and facilitating discussion.
Critics contend
No specific opposition is typically raised against short titles, as they are a standard and non-controversial legislative practice.
Tradeoffs
N/A
Section 2(a)
Establishment of TBI Innovation Grant Program
This section directs the Secretary of Veterans Affairs to establish a three-year "TBI Innovation Grant Program." Under this program, the VA will award grants to eligible entities for the development, implementation, and evaluation of approaches for prospective randomized control trials focused on neurorehabilitation treatments for chronic mild traumatic brain injury (mTBI) in veterans. The program is designed to supplement, rather than replace, existing VA research efforts.
Section 2(b)
Eligible Entities for TBI Innovation Grant Program
This subsection defines the types of organizations eligible to receive grants under the TBI Innovation Grant Program. Eligible entities include nonprofit organizations, academic institutions, non-Department health care providers, or partnerships formed by two or more of these. All must demonstrate a proven capability to conduct clinical trials and to deliver or research effective neurorehabilitation treatments for mTBI, including through patient care delivery.
Section 2(c)
Permitted Uses of Grant Funds for TBI Innovation Program
Grant recipients under the TBI Innovation Grant Program are required to use funds for specific activities. These include designing and testing novel or integrative mTBI treatments, with a priority on non-pharmacological therapies; conducting clinical studies to measure effectiveness on mental health outcomes, suicidality, and long-term durability; providing training for clinicians and outreach to veterans; and establishing partnerships with community organizations and VA facilities for referrals and dissemination of aggregate findings.
Section 3(a)
Establishment of Independent Third-Party Research Grant Program
This section directs the Secretary of Veterans Affairs to establish a separate research grant program. This program will award grants to eligible entities for conducting studies and applied programs focused on approaches and methodologies for the treatment of mTBI in veterans. Unlike the TBI Innovation Grant Program, this program is designed to be administered by an independent organization, emphasizing external oversight and evaluation.
Section 3(d)
Grant Categories and Nonprofit Priority for Independent Program
This subsection specifies the structure of grants under the independent research program. Each fiscal year, the Secretary is directed to award four grants of up to $625,000 for exploratory or pilot research projects, and five grants of up to $1,500,000 for collaborative or multidisciplinary research initiatives. A priority is given to nonprofit organizations, with at least three of the exploratory grants specifically reserved for them.
Section 3(e)
Agreement with Independent Organization for Program Administration
The Secretary is directed to seek an agreement with an independent organization (not part of the VA) that possesses demonstrated expertise in randomized controlled trials, neurorehabilitation outcomes evaluation, and research integrity. This organization would be responsible for administering the research grant program, analyzing data from mTBI treatments, identifying best practices, and conducting randomized, controlled clinical trials to validate treatments and establish standards of care. The organization must submit annual reports to the Secretary and Congress, detailing findings and recommendations.
Section 5
Extension of VA Housing Loan Fees
This section makes a technical amendment to section 3729(b)(2) of title 38, United States Code, by extending the expiration date for certain VA housing loan fees. The sunset date is moved from "June 9, 2034" to "July 14, 2034," effectively extending the collection of these fees by 35 days.
Extends the sunset date for certain VA housing loan fees by 35 days, from June 9, 2034, to July 14, 2034.
Section 5
Why it matters:This is standard legislative practice for technical or revenue-related adjustments that are not the primary policy focus of a bill but are necessary for its overall fiscal or programmatic structure. It is not necessarily evasive, but it is not highlighted as a central policy change.
Case for: Supporters would argue that this minor extension ensures continued funding for the VA's loan guarantee program, which helps veterans achieve homeownership, without requiring a separate legislative vehicle for such a small adjustment, thus promoting legislative efficiency.
Case against: Opponents of VA loan fees might argue that any extension, even a short one, continues a financial burden on veterans that should be eliminated, and that such extensions are often passed without sufficient scrutiny when attached to popular bills.
Estimated impact: A minor, short-term increase in revenue for the VA's loan guarantee program, and a corresponding minor, short-term cost for veterans taking out loans during that extended 35-day period. The exact dollar amount is not specified but would be proportional to 35 days of fee collection.